Trial challenges COPD drug fears

Tiotropium cuts mortality in COPD patients by 16 per cent compared with placebo, results of a 5,993-patient study show.

The long-acting anticholinergic drug, marketed as Spiriva, reduced exacerbations, delayed time to first exacerbation and cut the risk of exacerbations leading to hospital admission.

However, it failed to statistically significantly reduce decline in FEV1 after four years, the trial's primary endpoint.

The finding of reduced mortality contrasts with a recent JAMA analysis suggesting anticholinergics raise CVD risk.

  • NEJM 2008; 359: 1,543-54.

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

A 'tsunami' of work is drowning general practice: GPs speak out about a profession at its limit

A 'tsunami' of work is drowning general practice: GPs speak out about a profession at its limit

Rocketing workloads created by huge backlogs of cases and continuing COVID-19 disruption...

Slight increase in GP workforce in past year, but number of partners continues to fall

Slight increase in GP workforce in past year, but number of partners continues to fall

The GP workforce grew by 0.4% in the year to March 2021, but the number of GP partners...

Viewpoint: Patients and GPs are unhappy with access to general practice, what's the solution?

Viewpoint: Patients and GPs are unhappy with access to general practice, what's the solution?

Practices are deluged with work, yet many people still think they are ‘closed’. The...

Start date for COVID-19 booster campaign unclear, vaccines minister admits

Start date for COVID-19 booster campaign unclear, vaccines minister admits

A UK COVID-19 booster campaign could start from September - but could also remain...

BMA demands 'systemic change' after LMC report exposes racism in primary care

BMA demands 'systemic change' after LMC report exposes racism in primary care

Most black, Asian and minority ethnic primary care staff have experienced racism...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...